Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

Neurobiology of Disease

Volumn 31, Issue 1, 2008, Pages 127-132

  de Vrij, Femke M S ^a   Levenga, Josien ^a   van der Linde, Herma C ^a   Koekkoek, Sebastiaan K ^a   De Zeeuw, Chris I ^a   Nelson, David L ^b   Oostra, Ben A ^a   Willemsen, Rob ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dendrite branching; Fenobam; Fragile X syndrome; Metabotropic glutamate receptor; MPEP; Prepulse inhibition of startle; Primary hippocampal neuron culture; Spines

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; FRAGILE X MENTAL RETARDATION PROTEIN; GLUTAMATE RECEPTOR; RIBONUCLEOPROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITE; FRAGILE X SYNDROME; KNOCKOUT MOUSE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POLYSOME; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; RNA TRANSLATION; TRANSLATION REGULATION;

ANIMALS; BEHAVIOR, ANIMAL; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HIPPOCAMPUS; IMIDAZOLES; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NEURONS; PHENOTYPE; PYRIDINES; RECEPTORS, METABOTROPIC GLUTAMATE; STARTLE REACTION;

EID: 44949125523     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.04.002     Document Type: Article

References (46)

1. Antar L.N., et al. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav. 4 (2005) 350-359
2. Antar L.N., et al. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol. Cell. Neurosci. 32 (2006) 37-48
3. Bagni C., and Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev., Neurosci. 6 (2005) 376-387
4. Bakker C.E., et al. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78 (1994) 23-33
5. Bardoni B., et al. The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev. Mol. Med. 8 (2006) 1-16
6. Bear M.F., et al. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27 (2004) 370-377
7. Braun K., and Segal M. FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb. Cortex 10 (2000) 1045-1052
8. Catania M.V., et al. Endogenous activation of group-I metabotropic glutamate receptors is required for differentiation and survival of cerebellar Purkinje cells. J. Neurosci. 21 (2001) 7664-7673
9. Comery T.A., et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5401-5404
10. De Diego Otero Y., et al. Transport of fragile X mental retardation protein via granules in neurites of PC12 cells. Mol. Cell Biol. 22 (2002) 8332-8341
11. Dolen G., et al. Correction of fragile X syndrome in mice. Neuron 56 (2007) 955-962
12. Frankland P.W., et al. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol. Psychiatry 9 (2004) 417-425
13. Galvez R., and Greenough W.T. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am. J. Med. Genet A. 135 (2005) 155-160
14. Grauer S.M., and Marquis K.L. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats. Psychopharmacology (Berl). 141 (1999) 405-412
15. Greenough W.T., et al. Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7101-7106
16. Grossman A.W., et al. Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond. J. Neurosci. 26 (2006) 7151-7155
17. Henry S.A., et al. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology. 43 (2002) 1199-1209
18. Hinton V.J., et al. Analysis of neocortex in three males with the fragile X syndrome. Am. J. Med. Genet. 41 (1991) 289-294
19. Huber K.M., et al. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288 (2000) 1254-1257
20. Huber K.M., et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7746-7750
21. Koekkoek S.K., et al. Monitoring kinetic and frequency-domain properties of eyelid responses in mice with magnetic distance measurement technique. J. Neurophysiol. 88 (2002) 2124-2133
22. Koekkoek S.K., et al. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome. Neuron. 47 (2005) 339-352
23. Laggerbauer B., et al. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10 (2001) 329-338
24. Lea P.M.t., et al. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br. J. Pharmacol. 145 (2005) 527-534
25. Lu R., et al. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15201-15206
26. Matsuzaki M., et al. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat. Neurosci. 4 (2001) 1086-1092
27. McBride S.M., et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45 (2005) 753-764
28. Mientjes E.J., et al. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol. Dis. 21 (2006) 549-555
29. Miller L.J., et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am. J. Med. Genet. 83 (1999) 268-279
30. Miyashiro K.Y., et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37 (2003) 417-431
31. Muddashetty R.S., et al. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J. Neurosci. 27 (2007) 5338-5348
32. Musumeci S.A., et al. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41 (2000) 19-23
33. Nakamoto M., et al. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15537-15542
34. Nimchinsky E.A., et al. Abnormal development of dendritic spines in fmr1 knock-out mice. J. Neurosci. 21 (2001) 5139-5146
35. Okamura K., et al. Cadherin activity is required for activity-induced spine remodeling. J. Cell Biol. 167 (2004) 961-972
36. Papa M., et al. Morphological analysis of dendritic spine development in primary cultures of hippocampal neurons. J. Neurosci. 15 (1995) 1-11
37. Popoli P., et al. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre-and post-synaptic mechanisms and lack of direct NMDA blocking activity. J. Neurochem. 89 (2004) 1479-1489
38. Porter R.H., et al. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J. Pharmacol. Exp. Ther. 315 (2005) 711-721
39. Snyder E.M., et al. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4 (2001) 1079-1085
40. Spencer C.M., et al. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum. Mol. Genet. 15 (2006) 1884-1894
41. Wang H., et al. Dynamic association of the fragile X mental retardation protein as an mRNP between microtubules and polyribosomes. Mol. Biol. Cell. 19 1 (2008) 105-114
42. Weiler I.J., et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 5395-5400
43. Weiler I.J., et al. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17504-17509
44. Yan Q.J., et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology. 49 (2005) 1053-1066
45. Zalfa F., et al. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat. Neurosci. 10 5 (2007) 578-587
46. Zou D., et al. Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats. Neuropharmacology. 52 (2007) 476-486